Diagnosis-Specific Management of Somatoform Disorders: Moving Beyond “Vague Complaints of Pain”
Anne Dohrenwend, PhD
Characterized by unexplained somatic symptoms, often including pain amplification, somatoform disorders can be frustrating for clinicians to diagnosis and treat.
Reflection, Analysis and Change: The Decade of Pain Control and Research and its Lessons for the Future of Pain Management
James Giordano, PhD, M. Phil
The Decade of Pain Control and Research (2000-2010) has ushered in a new era in the practice of pain management.
Racial Differences in Osteoarthritis Pain and Function: Potential Explanatory Factors
Kelli D. Allen, PhD
Multiple studies of African-American patients have noted differences in osteoarthritis (OA) symptoms compared with Caucasians, including higher levels of reported pain and increased limitations in activity.
Gamma knife radiosurgery for multiple sclerosis–related trigeminal neuralgia
Douglas Kondziolka, MD, MSc
Multiple sclerosis related to trigeminal neuralgia (MSTN) is a severely disabling disorder characterized by paroxysmal episodes of face pain.
Racial and Ethnic Disparities in Pain: Causes and Consequences of Unequal Care
Karen O. Anderson, PhD, MPH
A review of the recent literature suggests that racial and ethnic disparities in pain assessment, analgesic treatment, and patient outcomes continue to exist across various acute and chronic pain conditions.
Creation of a Novel Recuperative Pain Medicine Service to Optimize Postoperative Analgesia and Enhance Patient Satisfaction
Brian D. Philips, RN, NP
The Hospital for Special Surgery in New York City has taken a number of important steps to improve postoperative pain management practices.
Economic Burden of Prescription Opioid Misuse and Abuse
Scott A. Strassels, PharmD, PhD, BCPS
Prescription opioid misuse and abuse are a serious public health problem, resulting in significant morbidity, mortality, and economic burden. Yet no other class of analgesic agents provides such broad spectrum efficacy for pain.
Ketamine for the Treatment of Intractable Pain Syndromes
Joshua P. Prager, MD, MS
Ketamine, originally developed in the 1960s as an anesthetic agent, is thought to derive its analgesic effect mainly due to antagonism of the N-methyl-d-aspartic acid (NMDA) receptor.
Assessment of Celiac Plexus Block and Neurolysis Outcomes and Technique in the Management of Refractory Visceral Cancer Pain.
Michael A. Erdek, MD
Objective: To assess demographic and clinical factors associated with celiac plexus neurolysis outcomes. Design. Retrospective clinical data analysis. Setting. A tertiary care, academic medical center.
A Clinical Trial of Gene Therapy for Chronic Pain
David J. Fink, MD
The treatment of pain with pharmacologic agents is often limited by dose-dependent side effects that develop when drugs are delivered systemically.
|
Association Links
|
e-Newsletter
|
